ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
NA: NA |
Rheumatold arthritis |
NA |
PTGS1; PTGS2; PTGS2; PTGS2 |
C00-D49: Neoplasms |
Hematological malignancies |
C81-C86 |
IDH1 |
C00-D49: Neoplasms |
Hormonally-responsive breast cancer |
C50 |
CYP19A1 |
NA: NA |
Gram-positive bacterial infection |
NA |
FASN |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
PTGS2; PTGS2; PTGS2; PTGS2 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Knee osteoarthritis |
M15-M19, M47 |
PTGS2 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Acne vulgaris |
L70.0 |
PTGS1 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Hyperthermia |
T68 |
PTGS2 |
NA: NA |
Joint and muscular pain |
NA |
PTGS2 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Arthritis |
M00-M25 |
PTGS2; PTGS2 |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
PTGS2 |
K00-K95: Diseases of the digestive system |
Inflammatory bowel disease |
K50, K51 |
PTGS1; PTGS2 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Inflammation |
E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 |
PTGS2 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Dietary shortage |
E40-E46 |
PTGS1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Gout |
M10 |
PTGS2 |
A00-B99: Certain infectious and parasitic diseases |
Mycobacterium tuberculosis infection |
A15-A19 |
FASN |
N00-N99: Diseases of the genitourinary system |
Prostate disease |
N42.9 |
CYP19A1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
PTGS2 |
G00-G99: Diseases of the nervous system G00-G99 |
Neuropathic pain |
G64, G90.0 |
PTGS1; PTGS2; PTGS2 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Ankylosing spondylitis |
M08.1, M45 |
PTGS2 |
K00-K95: Diseases of the digestive system |
Ulcerative colitis |
K51 |
PTGS1 |
C00-D49: Neoplasms |
Non-small cell lung cancer |
C33-C34 |
PTGS2 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Chronic pain |
R52.1-R52.2, G89 |
PTGS2 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Osteoarthritis |
M15-M19, M47 |
PTGS1; PTGS2; PTGS2; PTGS2; PTGS2; PTGS2; PTGS2 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Dermatitis |
L20-L30 |
PTGS1 |
C00-D49: Neoplasms |
Bladder cancer |
C67 |
CYP19A1 |
C00-D49: Neoplasms |
Pancreatic cancer |
C25 |
PTGS2 |
G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
PTGS1; PTGS2; PTGS2; PTGS2; PTGS2 |
G00-G99: Diseases of the nervous system G00-G99 |
Alzheimer disease |
G30 |
PTGS2 |
C00-D49: Neoplasms |
Breast cancer |
C50 |
CYP19A1 |
C00-D49: Neoplasms |
Advanced solid tumor |
C00-C75, C7A, C7B |
FASN |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Dramatic weight loss |
R63.4 |
FASN |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic neuropathy |
E11.40 |
PTGS1 |
C00-D49: Neoplasms |
Advanced breast cancer |
C50 |
CYP19A1 |
N00-N99: Diseases of the genitourinary system |
Endometriosis |
N80 |
PTGS2; CYP19A1 |
N00-N99: Diseases of the genitourinary system |
Dysmenorrhea |
N94.4-N94.6 |
PTGS1; PTGS2; PTGS2; PTGS2; PTGS2 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Moderate to severe rheumatoid arthritis |
M05-M06 |
PTGS2 |
NA: NA |
Miosis during ocular surgery |
NA |
PTGS1 |
A00-B99: Certain infectious and parasitic diseases |
Fungal infections |
B35-B49 |
FASN |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
PTGS1; PTGS2 |
C00-D49: Neoplasms |
Colorectal cancer |
C18-C21 |
PTGS1 |
K00-K95: Diseases of the digestive system |
Colon polyps |
K63.5 |
PTGS2 |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
PTGS2; FASN |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Postoperative inflammation |
T81 |
PTGS1 |